Company / Operating Income
STANDARD BIOTOOLS INC. Operating Income History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
-$76.6M
FY2025
5-year range
-$116.2M / -$51.8M
FY2021-FY2025
Trend
+34.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Income has fluctuated over the past 10 years, ranging from -$116M in FY2024 to -$48M in FY2020.
Based on SEC 10-K filings.
-$77M in FY2025.
Improved from -$116M to -$77M over the past 2 years.
Operating Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating income increased 34.1% year-over-year.
- Peak operating income was recorded in FY2020.
- Lowest operating income in the period was in FY2024.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$76.6M | +34.1% |
| FY2024 | -$116.2M | +0.0% |
| FY2023 | -$116.2M | -72.3% |
| FY2022 | -$67.5M | -30.1% |
| FY2021 | -$51.8M | -7.6% |
| FY2020 | -$48.2M | +17.5% |
| FY2019 | -$58.4M | +20.3% |
| FY2018 | -$73.2M | -45.9% |
| FY2017 | -$50.2M | +3.2% |
| FY2016 | -$51.8M | -177.9% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026